While shared pathophysiological mechanisms such as systemic inflammatory pathway activation and MMP involvement in vascular dysfunction exist, they have not been documented with the same depth, nor are there comparative clinical studies that directly quantify the relative contribution of MMP-3 to MACE induction in AS versus RA. Here, MMP3 is linked to rheumatoid arthritis.